Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris

Completed · Phase 3

Conditions studied: Acne Vulgaris

In brief

Participant Reported Outcomes with use of Trifarotene 50 μg/g Cream in participants with Moderate Facial and Truncal Acne Vulgaris

Key facts

Study ID

NCT03915860

Run by

Galderma R&D

People needed

47

Starts

2019-03-27

Expected to finish

2019-12-23

Last updated by the study team

2021-12-15

Who can join

Age: 9 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The participant was a male or female, 9 years of age or older, at Screening visit.
• The participant had moderate acne at Screening and Baseline.
• The participant was a female of non childbearing potential.
• The participant was a female of childbearing potential with a negative pregnancy test and who was strictly abstinent or who agreed to use an effective and approved contraceptive method for the duration of the study and at least 1 months after the last study drug application.

You may not qualify if…

• The participant had severe forms of acne (e.g., acne conglobate, acne fulminant) or secondary acne form (e.g., chloracne, drug induced acne, etc.).
• The participant had any uncontrolled or serious disease or any medical or surgical condition that may either interfere with the interpretation of the trial results and/or put the participant at significant risk (according to the Investigator's judgment) if the participant took part to the trial.
• The participant had been exposed to excessive ultraviolet (UV) radiation within one month prior to the Baseline visit or the participant was planning intense UV exposure during the study (i.ed, occupational exposure to the sun, sunbathing, tanning salon use, phototherapy, etc.).
• The participant was unwilling to refrain from use of prohibited medication during the Clinical Trial.

Where it is running

• Galderma Investigational Site — Fort Smith, Arkansas, United States
• Galderma Investigational Site — Beverly, Massachusetts, United States
• Galderma Investigational Site — Portsmouth, New Hampshire, United States
• Galderma Investigational Site — Philadelphia, Pennsylvania, United States
• Galderma Investigational Site — Austin, Texas, United States
• Galderma Investigational Site — Beaumont, Texas, United States
• Galderma Investigational Site — Irving, Texas, United States
• Galderma Investigational Site — Pflugerville, Texas, United States
• Galderma Investigational Site — Richardson, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.